© Pint of Science, 2021. All rights reserved.
Breast cancer is the most commonly diagnosed cancer in UK women. Research into this disease is ever ongoing as scientists and clinicians strive to improve patient outcomes. Join us for the evening as we explore the use of AI in mammograms, look into metal-based drugs as a new breast cancer therapy and see how the gut may influence breast health.
Back to the future: artificial intelligence and health
Artificial intelligence and machine learning are terms that are cropping up more and more frequently. Some articles in the media portray AI as transformational, while others have described it as dangerous, risky and scary. But what exactly is AI - what are its strengths, biases and weaknesses and when was the concept first introduced? In this discussion, Lisa goes Back to the Future to investigate AI and how and why it could now be applied to our health.
Metal-based drugs – are they the future for breast cancer treatment?
Many clinical anticancer drugs are based on toxic heavy metals, which are expensive and lack selectivity for the treatment of tumours. This leads to adverse side-effects in patients, which can impact negatively on their quality of life. This talk will discuss how clinical drugs work, how we as chemists can help improve the drug's selectivity and what the future looks for metal-based cancer drugs.
Breast health and the gut microbiota: an unlikely link?
Breast cancer is the leading cause of cancer-related deaths in women globally, and the second most common cause of cancer death in the UK. Initiation and development of cancer relies on cancer cells evading the immune system. In recent years, research has shown that our gut bacteria can influence the immune system, it has even shown to influence anti-cancer therapy outcomes. As such, could our local gut bacteria influence the development of breast cancer- and more broadly speaking breast health?